Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating CVnCoV vaccine safety and immunogenicity in healthy adults completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2 Disease

Drugs mentioned

• CVnCoV (CVnCoV)

Snippet

Sponsor: CureVac | Conditions: Coronavirus, Covid19 | Phase 3 | Status: COMPLETED | Results posted: 2023-10-06